Skip Nav Destination
Issues
15 March 2022
-
Cover Image
Cover Image
The image depicts the Battle of Chibi (meaning ‘Red Cliff’ in Chinese), one of the most famous battles in Chinese history. In the Battle of Chibi (208 AD), two groups joined forces to halt the advance of strong enemies. Similarly, Sun and colleagues target MYC-driven cancer with the combined inactivation of CTPS1 and ATR in this issue. The image depicts the two forces (in the shape of arrowheads) joining the battle (depicted by the fire). For details, see the article by Sun and colleagues on page 1013. (Concept, Ji-Long Liu; Illustration, Jia Du.)Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Insights
Review
Cancer Research Landmarks
Cancer Research Highlights
Genome and Epigenome
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis
Antonin Marchais; Maria Eugenia Marques da Costa; Bastien Job; Rachid Abbas; Damien Drubay; Sophie Piperno-Neumann; Olivia Fromigué; Anne Gomez-Brouchet; Françoise Redini; Robin Droit; Cyril Lervat; Natacha Entz-Werle; Hélène Pacquement; Catherine Devoldere; Didier Cupissol; Damien Bodet; Virginie Gandemer; Marc Berger; Perrine Marec-Berard; Marta Jimenez; Gilles Vassal; Birgit Geoerger; Laurence Brugières; Nathalie Gaspar
Metabolism and Chemical Biology
Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma
Julie Devin; Tatiana Cañeque; Yea-Lih Lin; Lucie Mondoulet; Jean-Luc Veyrune; Matthieu Abouladze; Elvira Garcia De Paco; Ouissem Karmous Gadacha; Guillaume Cartron; Philippe Pasero; Caroline Bret; Raphaël Rodriguez; Jerome Moreaux
Molecular Cell Biology
Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma
Huijing Yin; Bo Jing; Dongliang Xu; Wenzheng Guo; Beibei Sun; Jie Zhang; Yueling Liao; Hongyong Song; Tong Wang; Shuli Liu; Yanbin Kuang; Min Hu; Kaimi Li; Siwei Zhang; Hongjia Zhang; Jianhua Xu; Xue Li; Jing Du; Yadi Wu; Yingli Wu; Qi Wang; Feng Yao; Yueh Eugene Chin; Binhua P. Zhou; Jiong Deng
Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer
Upasana Ray; Deok-Beom Jung; Ling Jin; Yinan Xiao; Subramanyam Dasari; Sayantani Sarkar Bhattacharya; Prabhu Thirusangu; Julie K. Staub; Debarshi Roy; Bhaskar Roy; S. John Weroha; Xiaonan Hou; James W. Purcell; Jamie N. Bakkum-Gamez; Scott H. Kaufmann; Nagarajan Kannan; Anirban K. Mitra; Viji Shridhar
Tumor Biology and Immunology
EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation
Xiaobing Duan; Haiwen Chen; Xiang Zhou; Pingjuan Liu; Xiao Zhang; Qian Zhu; Ling Zhong; Wanlin Zhang; Shanshan Zhang; Xinyu Zhang; Yanhong Chen; Yan Zhou; Chaopin Yang; Qisheng Feng; Yi-Xin Zeng; Miao Xu; Tong Xiang
Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition
Nezihi Murat Karabacak; Yu Zheng; Taronish D. Dubash; Risa Burr; Douglas S. Micalizzi; Ben S. Wittner; Maoxuan Lin; Devon F. Wiley; Valentine Comaills; Erin Emmons; Kira L. Niederhoffer; Uyen Ho; Jacob Ukleja; Dante Che; Hannah Stowe; Linda T. Nieman; Wilhelm Haas; Shannon L. Stott; Michael S. Lawrence; David T. Ting; David T. Miyamoto; Daniel A. Haber; Mehmet Toner; Shyamala Maheswaran
Translational Science
Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice
Ana Casado-García; Marta Isidro-Hernández; Ninad Oak; Andrea Mayado; Christine Mann-Ran; Javier Raboso-Gallego; Silvia Alemán-Arteaga; Alexandra Buhles; Dario Sterker; Elena G. Sánchez; Jorge Martínez-Cano; Oscar Blanco; Alberto Orfao; Diego Alonso-López; Javier De Las Rivas; Susana Riesco; Pablo Prieto-Matos; África González-Murillo; Francisco Javier García Criado; María Begoña García Cenador; Thomas Radimerski; Manuel Ramírez-Orellana; César Cobaleda; Jun J. Yang; Carolina Vicente-Dueñas; Andreas Weiss; Kim E. Nichols; Isidro Sánchez-García
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib
Zena Wilson; Rajesh Odedra; Yann Wallez; Paul W.G. Wijnhoven; Adina M. Hughes; Joe Gerrard; Gemma N. Jones; Hannah Bargh-Dawson; Elaine Brown; Lucy A. Young; Mark J. O'Connor; Alan Lau
Corrections
Advertisement